Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vistra ITCL India Ltd Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 24, 2020 for Pronomz Ventures LLP Strides Pharma Science Ltd - 532531 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Strides Pharma Science Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Strides Pharma Science Ltd - 532531 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of 29th Annual General Meeting of the Company and Disclosure under SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015: Voting Results as required under Regulation 44 of SEBI Listing Regulations Strides Pharma Science Ltd - 532531 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Outcome of 29th Annual General Meeting of the Company and Disclosure under SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
Strides Pharma share price jumps 7% on US FDA nod for Ursodiol tablets
Strides Pharma Science's step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore received approval for Ursodiol Tablets USP, 250 mg and 500 mg from the USFDA. Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Strides receives USFDA approval for Ursodiol Tablets Strides Pharma Science Ltd - 532531 - Shareholder Meeting / Postal Ballot-Outcome of AGM
We wish to inform you that the 29th Annual General Meeting ('AGM') of the Company was held today i.e., on Thursday, August 20, 2020. In this connection, please find enclosed the summary of proceedings of the AGM as required under Regulation 30 of SEBI Listing Regulations. This is for your information and records. Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Strides announces successful completion of UK MHRA inspection at Puducherry facility Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 16, 2020 for Abusha Investment & Management Services LLP